MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia

Published:2023-02 Issue: Volume:67 Page:101893
ISSN:0890-8508
Container-title:Molecular and Cellular Probes
language:en
Short-container-title:Molecular and Cellular Probes

Author:

Rzepiel Andrea,Horváth Anna,Kutszegi Nóra,Gézsi András,Sági Judit C.,Almási Laura,Egyed Bálint,Lőrincz Péter,Visnovitz Tamás,Kovács Gábor T.,Szalai Csaba,Semsei Ágnes F.^ORCID,Erdélyi Dániel J.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference53 articles.

1. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies;van Dongen;Blood,2015

2. Acute lymphoblastic leukaemia;Pui;Lancet,2008

3. Childhood acute lymphoblastic leukemia: update on prognostic factors;Vrooman;Curr. Opin. Pediatr.,2009

4. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL;Wood;Blood,2018

5. Role of microRNA dysregulation in childhood acute leukemias: diagnostics, monitoring and therapeutics: a comprehensive review;Szczepanek;World J. Clin. Oncol.,2020

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LincRNA-MSTRG.673.2 Promotes Chicken Intramuscular Adipocyte Differentiation by Sponging miR- 128-3p;2024-05-23

2. Small extracellular vesicles from surviving cancer cells as multiparametric monitoring tools of measurable residual disease and therapeutic efficiency;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

3. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia;Medical Oncology;2024-01-23

4. Advancements in the Regulatory Role of microRNAs in Childhood Acute Lymphoblastic Leukemia: Mechanisms and Clinical Implications;Technology in Cancer Research & Treatment;2024-01

5. Pattern Recognition of Acute Lymphoblastic Leukemia (ALL) Using Computational Deep Learning;IEEE Access;2023